Most cancers excel at staying hidden until it’s too late. By the time symptoms appear, the disease often has spread beyond ...

Cornell-led study reveals promising RNA biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), offering ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...

A study reveals potential biomarkers in blood samples that could pave the way for a diagnostic blood test for chronic fatigue ...

A single blood draw that can detect 50 different types of cancer sounds like science fiction, but it's already available to ...

Researchers at Arizona State University have developed a breakthrough diagnostic tool that could transform how quickly and ...

The test, developed in part by Johns Hopkins researchers, will dramatically increase access to early detection and treatment ...

The method assesses growth rates of the tumour and detects gene patterns that can forecast outcomes of the patient.

The test looks for certain proteins in the blood which show the immune system is responding to the first signs of cancer ...

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...

Blood tests like Galleri can screen for that tumor DNA before people experience any telltale symptoms. These tests, however, don’t diagnose a specific cancer.